-+ 0.00%
-+ 0.00%
-+ 0.00%

Zimmer Biomet Q3 diluted EPS falls 14% to $1; Q3 net sales rise to $2.06 billion

PUBT·11/04/2026 11:38:02
Zimmer Biomet Q3 diluted EPS falls 14% to $1; Q3 net sales rise to $2.06 billion
  • Zimmer Biomet’s third-quarter 2026 diluted earnings per share fell 14% year over year to $1.
  • Net sales rose to $2.06 billion, while operating cash flow totaled $560 million.
  • The company extended its multiyear limited exclusive distribution and supply agreement with THINK Surgical to support its robotics portfolio.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zimmer Biomet Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-446145), on November 04, 2026, and is solely responsible for the information contained therein.